questionsmedicales.fr
Maladies du système nerveux
Tumeurs du système nerveux
Tumeurs du système nerveux central
Tumeurs du système nerveux central : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Tumeurs du système nerveux central
Imagerie par résonance magnétique
Biopsie
Tumeurs cérébrales
Tomodensitométrie
Tests neurologiques
Marqueurs tumoraux
Tumeurs du système nerveux central
Protéines gliales
Imagerie médicale
Tumeurs du système nerveux central
Évaluation radiologique
Échographie
Tumeurs du système nerveux central
Imagerie par résonance magnétique
Symptômes
5
Symptômes neurologiques
Tumeurs du système nerveux central
Maux de tête
Fonction cognitive
Tumeurs du système nerveux central
Troubles de la mémoire
Convulsions
Tumeurs cérébrales
Épilepsie
Signes neurologiques
Tumeurs du système nerveux central
Faiblesse musculaire
Changements d'humeur
Tumeurs du système nerveux central
Comportement
Prévention
5
Prévention
Tumeurs du système nerveux central
Expositions environnementales
Radiations
Tumeurs du système nerveux central
Facteurs de risque
Infections virales
Tumeurs du système nerveux central
Virus Epstein-Barr
Mode de vie
Tumeurs du système nerveux central
Facteurs de risque
Antécédents familiaux
Tumeurs du système nerveux central
Facteurs de risque
Traitements
5
Chirurgie
Radiothérapie
Chimiothérapie
Chirurgie
Tumeurs du système nerveux central
Résection tumorale
Radiothérapie
Tumeurs du système nerveux central
Traitement adjuvant
Chimiothérapie
Tumeurs du système nerveux central
Sensibilité tumorale
Effets secondaires
Tumeurs du système nerveux central
Chimiothérapie
Complications
5
Complications
Tumeurs du système nerveux central
Déficits neurologiques
Mobilité
Tumeurs du système nerveux central
Coordination
Qualité de vie
Tumeurs du système nerveux central
Douleur
Épilepsie
Tumeurs du système nerveux central
Crises
Conséquences psychologiques
Tumeurs du système nerveux central
Anxiété
Facteurs de risque
5
Facteurs de risque
Tumeurs du système nerveux central
Maladies génétiques
Âge
Tumeurs du système nerveux central
Facteurs de risque
Troubles immunitaires
Tumeurs du système nerveux central
Facteurs de risque
Produits chimiques
Tumeurs du système nerveux central
Expositions professionnelles
Infections
Tumeurs du système nerveux central
VIH
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Tumeurs du système nerveux central : Questions médicales les plus fréquentes",
"headline": "Tumeurs du système nerveux central : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Tumeurs du système nerveux central : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-08",
"dateModified": "2025-04-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Tumeurs du système nerveux central"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Tumeurs du système nerveux",
"url": "https://questionsmedicales.fr/mesh/D009423",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs du système nerveux",
"code": {
"@type": "MedicalCode",
"code": "D009423",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Tumeurs du cerveau",
"alternateName": "Brain Neoplasms",
"url": "https://questionsmedicales.fr/mesh/D001932",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs du cerveau",
"code": {
"@type": "MedicalCode",
"code": "D001932",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Tumeurs des ventricules cérébraux",
"alternateName": "Cerebral Ventricle Neoplasms",
"url": "https://questionsmedicales.fr/mesh/D002551",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs des ventricules cérébraux",
"code": {
"@type": "MedicalCode",
"code": "D002551",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.200"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Tumeurs du plexus choroïde",
"alternateName": "Choroid Plexus Neoplasms",
"url": "https://questionsmedicales.fr/mesh/D016545",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs du plexus choroïde",
"code": {
"@type": "MedicalCode",
"code": "D016545",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.200.200"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Papillome du plexus choroïde",
"alternateName": "Papilloma, Choroid Plexus",
"url": "https://questionsmedicales.fr/mesh/D020288",
"about": {
"@type": "MedicalCondition",
"name": "Papillome du plexus choroïde",
"code": {
"@type": "MedicalCode",
"code": "D020288",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.200.200.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Papillome du plexus choroïde",
"alternateName": "Papilloma, Choroid Plexus",
"url": "https://questionsmedicales.fr/mesh/D020288",
"about": {
"@type": "MedicalCondition",
"name": "Papillome du plexus choroïde",
"code": {
"@type": "MedicalCode",
"code": "D020288",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.200.200.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Tumeurs du plexus choroïde",
"alternateName": "Choroid Plexus Neoplasms",
"url": "https://questionsmedicales.fr/mesh/D016545",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs du plexus choroïde",
"code": {
"@type": "MedicalCode",
"code": "D016545",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.200.200"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Papillome du plexus choroïde",
"alternateName": "Papilloma, Choroid Plexus",
"url": "https://questionsmedicales.fr/mesh/D020288",
"about": {
"@type": "MedicalCondition",
"name": "Papillome du plexus choroïde",
"code": {
"@type": "MedicalCode",
"code": "D020288",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.200.200.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Papillome du plexus choroïde",
"alternateName": "Papilloma, Choroid Plexus",
"url": "https://questionsmedicales.fr/mesh/D020288",
"about": {
"@type": "MedicalCondition",
"name": "Papillome du plexus choroïde",
"code": {
"@type": "MedicalCode",
"code": "D020288",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.200.200.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tumeurs sous-tentorielles",
"alternateName": "Infratentorial Neoplasms",
"url": "https://questionsmedicales.fr/mesh/D015192",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs sous-tentorielles",
"code": {
"@type": "MedicalCode",
"code": "D015192",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.400"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Tumeurs du tronc cérébral",
"alternateName": "Brain Stem Neoplasms",
"url": "https://questionsmedicales.fr/mesh/D020295",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs du tronc cérébral",
"code": {
"@type": "MedicalCode",
"code": "D020295",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.400.200"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Gliome infiltrant du tronc cérébral",
"alternateName": "Diffuse Intrinsic Pontine Glioma",
"url": "https://questionsmedicales.fr/mesh/D000080443",
"about": {
"@type": "MedicalCondition",
"name": "Gliome infiltrant du tronc cérébral",
"code": {
"@type": "MedicalCode",
"code": "D000080443",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.400.200.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Gliome infiltrant du tronc cérébral",
"alternateName": "Diffuse Intrinsic Pontine Glioma",
"url": "https://questionsmedicales.fr/mesh/D000080443",
"about": {
"@type": "MedicalCondition",
"name": "Gliome infiltrant du tronc cérébral",
"code": {
"@type": "MedicalCode",
"code": "D000080443",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.400.200.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tumeurs du cervelet",
"alternateName": "Cerebellar Neoplasms",
"url": "https://questionsmedicales.fr/mesh/D002528",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs du cervelet",
"code": {
"@type": "MedicalCode",
"code": "D002528",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.400.300"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Tumeurs du tronc cérébral",
"alternateName": "Brain Stem Neoplasms",
"url": "https://questionsmedicales.fr/mesh/D020295",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs du tronc cérébral",
"code": {
"@type": "MedicalCode",
"code": "D020295",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.400.200"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Gliome infiltrant du tronc cérébral",
"alternateName": "Diffuse Intrinsic Pontine Glioma",
"url": "https://questionsmedicales.fr/mesh/D000080443",
"about": {
"@type": "MedicalCondition",
"name": "Gliome infiltrant du tronc cérébral",
"code": {
"@type": "MedicalCode",
"code": "D000080443",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.400.200.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Gliome infiltrant du tronc cérébral",
"alternateName": "Diffuse Intrinsic Pontine Glioma",
"url": "https://questionsmedicales.fr/mesh/D000080443",
"about": {
"@type": "MedicalCondition",
"name": "Gliome infiltrant du tronc cérébral",
"code": {
"@type": "MedicalCode",
"code": "D000080443",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.400.200.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tumeurs du cervelet",
"alternateName": "Cerebellar Neoplasms",
"url": "https://questionsmedicales.fr/mesh/D002528",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs du cervelet",
"code": {
"@type": "MedicalCode",
"code": "D002528",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.400.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Neurocytome",
"alternateName": "Neurocytoma",
"url": "https://questionsmedicales.fr/mesh/D018306",
"about": {
"@type": "MedicalCondition",
"name": "Neurocytome",
"code": {
"@type": "MedicalCode",
"code": "D018306",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.550"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Pinéalome",
"alternateName": "Pinealoma",
"url": "https://questionsmedicales.fr/mesh/D010871",
"about": {
"@type": "MedicalCondition",
"name": "Pinéalome",
"code": {
"@type": "MedicalCode",
"code": "D010871",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.625"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tumeurs sus-tentorielles",
"alternateName": "Supratentorial Neoplasms",
"url": "https://questionsmedicales.fr/mesh/D015173",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs sus-tentorielles",
"code": {
"@type": "MedicalCode",
"code": "D015173",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.700"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Tumeurs de l'hypothalamus",
"alternateName": "Hypothalamic Neoplasms",
"url": "https://questionsmedicales.fr/mesh/D007029",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs de l'hypothalamus",
"code": {
"@type": "MedicalCode",
"code": "D007029",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.700.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Tumeurs de l'hypothalamus",
"alternateName": "Hypothalamic Neoplasms",
"url": "https://questionsmedicales.fr/mesh/D007029",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs de l'hypothalamus",
"code": {
"@type": "MedicalCode",
"code": "D007029",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.250.700.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Tumeurs des méninges",
"alternateName": "Meningeal Neoplasms",
"url": "https://questionsmedicales.fr/mesh/D008577",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs des méninges",
"code": {
"@type": "MedicalCode",
"code": "D008577",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Méningite carcinomateuse",
"alternateName": "Meningeal Carcinomatosis",
"url": "https://questionsmedicales.fr/mesh/D055756",
"about": {
"@type": "MedicalCondition",
"name": "Méningite carcinomateuse",
"code": {
"@type": "MedicalCode",
"code": "D055756",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.500.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Méningiome",
"alternateName": "Meningioma",
"url": "https://questionsmedicales.fr/mesh/D008579",
"about": {
"@type": "MedicalCondition",
"name": "Méningiome",
"code": {
"@type": "MedicalCode",
"code": "D008579",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.500.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Tumeurs de la moelle épinière",
"alternateName": "Spinal Cord Neoplasms",
"url": "https://questionsmedicales.fr/mesh/D013120",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs de la moelle épinière",
"code": {
"@type": "MedicalCode",
"code": "D013120",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.750"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Tumeurs épidurales",
"alternateName": "Epidural Neoplasms",
"url": "https://questionsmedicales.fr/mesh/D015174",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs épidurales",
"code": {
"@type": "MedicalCode",
"code": "D015174",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.551.240.750.200"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs du système nerveux central",
"alternateName": "Central Nervous System Neoplasms",
"code": {
"@type": "MedicalCode",
"code": "D016543",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Christian Grommes",
"url": "https://questionsmedicales.fr/author/Christian%20Grommes",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Daniel R Rissi",
"url": "https://questionsmedicales.fr/author/Daniel%20R%20Rissi",
"affiliation": {
"@type": "Organization",
"name": "University of Georgia, Athens, GA."
}
},
{
"@type": "Person",
"name": "Lakshmi Nayak",
"url": "https://questionsmedicales.fr/author/Lakshmi%20Nayak",
"affiliation": {
"@type": "Organization",
"name": "Department of Medical Oncology, Center for Neuro-Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: Lakshmi_Nayak@dfci.harvard.edu."
}
},
{
"@type": "Person",
"name": "Ammar A Chaudhry",
"url": "https://questionsmedicales.fr/author/Ammar%20A%20Chaudhry",
"affiliation": {
"@type": "Organization",
"name": "Precision Imaging Lab, Department of Diagnostic Radiology, City of Hope National Cancer Center, 1500 East Duarte Road, Los Angeles, CA 91010, USA. Electronic address: achaudhry@coh.org."
}
},
{
"@type": "Person",
"name": "Sohaib Naim",
"url": "https://questionsmedicales.fr/author/Sohaib%20Naim",
"affiliation": {
"@type": "Organization",
"name": "Department of Diagnostic Radiology, City of Hope National Cancer Center, 1500 East Duarte Road, Los Angeles, CA 91010, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Non-occlusive Mesenteric Ischemia with Significant Hyperphosphatemia.",
"datePublished": "2022-07-29",
"url": "https://questionsmedicales.fr/article/35908963",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2169/internalmedicine.0074-22"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hyperphosphatemia during nutrition recovery in patients with severe anorexia nervosa.",
"datePublished": "2022-11-24",
"url": "https://questionsmedicales.fr/article/36437197",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.endien.2021.12.010"
}
},
{
"@type": "ScholarlyArticle",
"name": "Refractoriness of Hyperkalemia and Hyperphosphatemia in Dialysis-Dependent AKI Associated with COVID-19.",
"datePublished": "2022-05-18",
"url": "https://questionsmedicales.fr/article/36176653",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.34067/KID.0001632022"
}
},
{
"@type": "ScholarlyArticle",
"name": "Understudied Hyperphosphatemia (Chronic Kidney Disease) Treatment Targets and New Biological Approaches.",
"datePublished": "2023-05-16",
"url": "https://questionsmedicales.fr/article/37241191",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/medicina59050959"
}
},
{
"@type": "ScholarlyArticle",
"name": "Key regulators of vascular calcification in chronic kidney disease: Hyperphosphatemia, BMP2, and RUNX2.",
"datePublished": "2024-09-19",
"url": "https://questionsmedicales.fr/article/39308809",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7717/peerj.18063"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système nerveux",
"item": "https://questionsmedicales.fr/mesh/D009422"
},
{
"@type": "ListItem",
"position": 3,
"name": "Tumeurs du système nerveux",
"item": "https://questionsmedicales.fr/mesh/D009423"
},
{
"@type": "ListItem",
"position": 4,
"name": "Tumeurs du système nerveux central",
"item": "https://questionsmedicales.fr/mesh/D016543"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Tumeurs du système nerveux central - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Tumeurs du système nerveux central",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Tumeurs du système nerveux central",
"description": "Comment diagnostique-t-on une tumeur du SNC ?\nQuels tests sont utilisés pour évaluer une tumeur cérébrale ?\nQuels marqueurs tumoraux sont associés aux tumeurs du SNC ?\nQuelle est l'importance de l'imagerie dans le diagnostic ?\nPeut-on diagnostiquer une tumeur du SNC par échographie ?",
"url": "https://questionsmedicales.fr/mesh/D016543?mesh_terms=Hyperphosphatemia#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Tumeurs du système nerveux central",
"description": "Quels sont les symptômes courants des tumeurs du SNC ?\nComment les tumeurs affectent-elles la fonction cognitive ?\nLes tumeurs du SNC causent-elles des convulsions ?\nQuels signes neurologiques peuvent indiquer une tumeur ?\nLes tumeurs du SNC provoquent-elles des changements d'humeur ?",
"url": "https://questionsmedicales.fr/mesh/D016543?mesh_terms=Hyperphosphatemia#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Tumeurs du système nerveux central",
"description": "Peut-on prévenir les tumeurs du SNC ?\nLes radiations augmentent-elles le risque de tumeurs du SNC ?\nLes infections virales peuvent-elles causer des tumeurs du SNC ?\nLe mode de vie influence-t-il le risque de tumeurs du SNC ?\nLes antécédents familiaux augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D016543?mesh_terms=Hyperphosphatemia#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Tumeurs du système nerveux central",
"description": "Quels sont les traitements possibles pour les tumeurs du SNC ?\nQuand la chirurgie est-elle recommandée pour une tumeur du SNC ?\nQuel rôle joue la radiothérapie dans le traitement ?\nLa chimiothérapie est-elle efficace contre toutes les tumeurs du SNC ?\nQuels sont les effets secondaires des traitements ?",
"url": "https://questionsmedicales.fr/mesh/D016543?mesh_terms=Hyperphosphatemia#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Tumeurs du système nerveux central",
"description": "Quelles complications peuvent survenir après un traitement ?\nLes tumeurs du SNC peuvent-elles causer des problèmes de mobilité ?\nComment les tumeurs affectent-elles la qualité de vie ?\nLes tumeurs du SNC peuvent-elles entraîner des crises d'épilepsie ?\nQuelles sont les conséquences psychologiques des tumeurs du SNC ?",
"url": "https://questionsmedicales.fr/mesh/D016543?mesh_terms=Hyperphosphatemia#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Tumeurs du système nerveux central",
"description": "Quels sont les principaux facteurs de risque des tumeurs du SNC ?\nL'âge influence-t-il le risque de tumeurs du SNC ?\nLes troubles immunitaires augmentent-ils le risque ?\nLes produits chimiques peuvent-ils être un facteur de risque ?\nLes infections antérieures influencent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D016543?mesh_terms=Hyperphosphatemia#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on une tumeur du SNC ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par IRM, scanner et biopsie pour analyser les cellules."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer une tumeur cérébrale ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'IRM, le scanner et des tests neurologiques pour évaluer la fonction."
}
},
{
"@type": "Question",
"name": "Quels marqueurs tumoraux sont associés aux tumeurs du SNC ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des marqueurs comme le GFAP et l'IDH peuvent être utilisés pour certaines tumeurs."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'imagerie dans le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie permet de localiser la tumeur, d'évaluer sa taille et son impact sur le SNC."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer une tumeur du SNC par échographie ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'échographie est rarement utilisée pour le SNC, l'IRM et le scanner sont préférés."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des tumeurs du SNC ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des maux de tête, des nausées, des troubles de la vision et des convulsions."
}
},
{
"@type": "Question",
"name": "Comment les tumeurs affectent-elles la fonction cognitive ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent provoquer des troubles de la mémoire, de la concentration et des changements de personnalité."
}
},
{
"@type": "Question",
"name": "Les tumeurs du SNC causent-elles des convulsions ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les convulsions sont fréquentes et peuvent être un signe d'une tumeur cérébrale."
}
},
{
"@type": "Question",
"name": "Quels signes neurologiques peuvent indiquer une tumeur ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme la faiblesse musculaire, des engourdissements ou des troubles de l'équilibre peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les tumeurs du SNC provoquent-elles des changements d'humeur ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des changements d'humeur et des comportements peuvent survenir en raison de la pression sur le cerveau."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les tumeurs du SNC ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention garantie, mais éviter les expositions nocives peut aider."
}
},
{
"@type": "Question",
"name": "Les radiations augmentent-elles le risque de tumeurs du SNC ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition aux radiations ionisantes est un facteur de risque connu pour ces tumeurs."
}
},
{
"@type": "Question",
"name": "Les infections virales peuvent-elles causer des tumeurs du SNC ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections virales, comme le virus Epstein-Barr, sont associées à un risque accru."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque de tumeurs du SNC ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain peut réduire certains risques, mais les causes exactes restent souvent inconnues."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux augmentent-ils le risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de tumeurs cérébrales peuvent augmenter le risque individuel."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements possibles pour les tumeurs du SNC ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chirurgie, la radiothérapie et la chimiothérapie selon le type de tumeur."
}
},
{
"@type": "Question",
"name": "Quand la chirurgie est-elle recommandée pour une tumeur du SNC ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est souvent recommandée si la tumeur est accessible et peut être retirée sans risque majeur."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la radiothérapie dans le traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La radiothérapie est utilisée pour détruire les cellules tumorales, souvent après la chirurgie."
}
},
{
"@type": "Question",
"name": "La chimiothérapie est-elle efficace contre toutes les tumeurs du SNC ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, son efficacité varie selon le type de tumeur; certaines sont plus sensibles que d'autres."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des traitements ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure fatigue, nausées, troubles neurologiques et perte de cheveux."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après un traitement ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des déficits neurologiques, des infections et des récidives tumorales."
}
},
{
"@type": "Question",
"name": "Les tumeurs du SNC peuvent-elles causer des problèmes de mobilité ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent affecter la coordination et la force, entraînant des problèmes de mobilité."
}
},
{
"@type": "Question",
"name": "Comment les tumeurs affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent entraîner des douleurs, des troubles cognitifs et des impacts émotionnels significatifs."
}
},
{
"@type": "Question",
"name": "Les tumeurs du SNC peuvent-elles entraîner des crises d'épilepsie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent provoquer des crises d'épilepsie, nécessitant un traitement antiepileptique."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences psychologiques des tumeurs du SNC ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients peuvent éprouver anxiété, dépression et stress en raison de leur condition."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque des tumeurs du SNC ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'exposition aux radiations, les antécédents familiaux et certaines maladies génétiques."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de tumeurs du SNC ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente avec l'âge, bien que certaines tumeurs puissent survenir chez les jeunes."
}
},
{
"@type": "Question",
"name": "Les troubles immunitaires augmentent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes avec des troubles immunitaires ont un risque accru de développer des tumeurs."
}
},
{
"@type": "Question",
"name": "Les produits chimiques peuvent-ils être un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines expositions professionnelles à des produits chimiques sont suspectées d'augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les infections antérieures influencent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections, comme le VIH, peuvent augmenter le risque de tumeurs du SNC."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 03/04/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Publications dans "Tumeurs du système nerveux central" :
2 publications dans cette catégorie
Affiliations :
University of Georgia, Athens, GA.
Publications dans "Tumeurs du système nerveux central" :
2 publications dans cette catégorie
Affiliations :
Department of Medical Oncology, Center for Neuro-Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: Lakshmi_Nayak@dfci.harvard.edu.
Publications dans "Tumeurs du système nerveux central" :
2 publications dans cette catégorie
Affiliations :
Precision Imaging Lab, Department of Diagnostic Radiology, City of Hope National Cancer Center, 1500 East Duarte Road, Los Angeles, CA 91010, USA. Electronic address: achaudhry@coh.org.
Publications dans "Tumeurs du système nerveux central" :
2 publications dans cette catégorie
Affiliations :
Department of Diagnostic Radiology, City of Hope National Cancer Center, 1500 East Duarte Road, Los Angeles, CA 91010, USA.
Publications dans "Tumeurs du système nerveux central" :
2 publications dans cette catégorie
Affiliations :
Department of Diagnostic Radiology, City of Hope National Cancer Center, 1500 East Duarte Road, Los Angeles, CA 91010, USA.
Publications dans "Tumeurs du système nerveux central" :
2 publications dans cette catégorie
Affiliations :
Department of Diagnostic Radiology, City of Hope National Cancer Center, 1500 East Duarte Road, Los Angeles, CA 91010, USA.
Publications dans "Tumeurs du système nerveux central" :
2 publications dans cette catégorie
Affiliations :
Department of Neurosurgery, City of Hope National Cancer Center, 1500 East Duarte Road, Los Angeles, CA 91010, USA.
Publications dans "Tumeurs du système nerveux central" :
2 publications dans cette catégorie
Affiliations :
Department of Neurosurgery, City of Hope National Cancer Center, 1500 East Duarte Road, Los Angeles, CA 91010, USA.
Publications dans "Tumeurs du système nerveux central" :
2 publications dans cette catégorie
Affiliations :
Department of Neurosurgery, City of Hope National Cancer Center, 1500 East Duarte Road, Los Angeles, CA 91010, USA.
Publications dans "Tumeurs du système nerveux central" :
1 publication dans cette catégorie
Affiliations :
Lewis Katz School of Medicine, Temple University, Philadelphia, USA.
Publications dans "Tumeurs du système nerveux central" :
1 publication dans cette catégorie
Affiliations :
Neurosurgery, Main Line Health, Bryn Mawr, USA.
Publications dans "Tumeurs du système nerveux central" :
1 publication dans cette catégorie
Affiliations :
Neurosurgery, Thomas Jefferson University, Philadelphia, USA.
Publications dans "Tumeurs du système nerveux central" :
1 publication dans cette catégorie
Affiliations :
Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, United States. Electronic address: Chunyu.cai@utsouthwestern.edu.
Publications dans "Tumeurs du système nerveux central" :
1 publication dans cette catégorie
Affiliations :
Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA. Electronic address: dmmeredith@bwh.harvard.edu.
Publications dans "Tumeurs du système nerveux central" :
1 publication dans cette catégorie
Affiliations :
Department of Neurology, NewYork-Presbyterian Hospital, Weill Cornell Medicine, 528 East 68th Street, New York, NY, 10065, USA.
Publications dans "Tumeurs du système nerveux central" :
1 publication dans cette catégorie
Affiliations :
Department of Neurology, Indiana University Health, Indiana University School of Medicine, 355 W. 16th St., Ste 3200, Indianapolis, IN, 46202, USA. knevel@iupui.edu.
Publications dans "Tumeurs du système nerveux central" :
1 publication dans cette catégorie
Affiliations :
Institute of Surgical Gastroenterology, GI and HPB Oncosurgery and Liver Transplantation, Sir Ganga Ram Hospital, New Delhi 110060, India. Electronic address: suvu1078@gmail.com.
Publications dans "Tumeurs du système nerveux central" :
1 publication dans cette catégorie
Affiliations :
Institute of Surgical Gastroenterology, GI and HPB Oncosurgery and Liver Transplantation, Sir Ganga Ram Hospital, New Delhi 110060, India.
Publications dans "Tumeurs du système nerveux central" :
1 publication dans cette catégorie
Affiliations :
Radiology, Aga Khan University Hospital, Karachi, PAK.
Publications dans "Tumeurs du système nerveux central" :
An 86-year-old Japanese woman was referred to our hospital due to the sudden onset of abdominal pain. Abdominal contrast-enhanced computed tomography (CT) revealed no signs of ischemic bowel; however,...
Anorexia nervosa (AN) is a disorder associated with many medical complications. Regarding phosphorus metabolism, the only recognized alteration is hypophosphatemia associated with refeeding syndrome. ...
We carried out a retrospective study of patients with AN hospitalized for severe decompensation of the disease....
Eleven patients were included, all women, with a median age of 23 years [20-46] and a body mass index at admission of 12.2 kg/m...
Late hyperphosphatemia during nutrition therapy in severely undernourished AN patients affects more than 80% of cases. Body weight gain throughout nutrition therapy is a predictor of increased P level...
Persistent hyperkalemia (hyperK) and hyperphosphatemia (hyperP) despite renal replacement therapy (RRT) was anecdotally reported in COVID-19 and acute kidney injury (AKI) requiring RRT (CoV-AKI-RRT). ...
We identified patients with CoV-AKI-RRT treated with sustained low-efficiency dialysis (SLED) for ≥2 days in March-April 2020. As pre-COVID-19 control, we included patients with AKI treated with SLED ...
Along the duration of SLED, the incidence of hyperK was greater in CoV-AKI-RRT (...
Refractory hyperK and hyperP were more frequent in CoV-AKI-RRT compared with the pre-COVID-19 era. Because of the correlation of sK and sP with higher LDH and sP with shorter SLED runs, intracellular ...
Hyperphosphatemia is a secondary disorder of chronic kidney disease that causes vascular calcifications and bone-mineral disorders. As per the US Centers for Disease Control and Prevention, renal dama...
Vascular calcification is quite common in patients with end-stage chronic kidney disease and is a major trigger for cardiovascular complications in these patients. These complications significantly im...
Nonrespiratory manifestations of COVID-19 include endocrine disorders, among which are calcium-magnesium-phosphate homeostasis abnormalities, which seem to influence the disease severity and patient o...
The study was conducted between April 2020 and May 2021 at Central Clinical Hospital in Warsaw, Poland. A total of 146 patients who had tested concentration of at least one of the studied elements, es...
We found that hypermagnesemia was common and associated with a 1.5-fold increased risk of death in the whole cohort. Hyperphosphatemia also increased the risk of death, exactly 2.4-fold. Furthermore, ...
Hypermagnesemia, hyperphosphatemia, and hypovitaminosis D but not hypocalcemia influence the mortality of patients with COVID-19. These parameters should be monitored routinely in this group of patien...
Herein, we compared the association intensity of estimated glomerular filtration rate (eGFR) equations using creatinine (Cr) or cystatin C (CysC) with hyperphosphatemia and secondary hyperparathyroidi...
Hyperphosphatemia occurs frequently in end-stage renal disease patients on hemodialysis and is associated with increased mortality. Hyperphosphatemia contributes to vascular calcification in these pat...
We conducted a cross-sectional study in hypertensive hemodialysis patients. We obtained pre-hemodialysis measurements of total peripheral resistance index (TPRI, non-invasive cardiac output monitor) a...
There were 54 patients analyzed. Mean pre-HD supine and seated systolic and diastolic BP were 164 (27), 158 (21), 91.5 (17), and 86.1 (16) mmHg. Mean serum phosphate was 5.89 (1.8) mg/dL. There were s...
Serum phosphate concentration is independently associated with higher pre-HD BP, vasoconstriction, and markers of endothelial cell dysfunction. These findings demonstrate an additional negative impact...
The study was part of a registered clinical trial, NCT01862497 (May 24, 2013)....
Patients with chronic kidney disease (CKD), hyperkalemia (serum potassium [sK...
A post hoc pooled analysis of individual-level data from the AMETHYST-DN, OPAL-HK, and TOURMALINE trials of patiromer....
Patients with CKD and hyperkalemia....
Patients treated with patiromer (8.4-33.6 g/day)....
Mean changes from baseline in sP, sK...
Descriptive statistics to summarize pooled data on the study outcomes from the 3 studies....
We included 578 patients in the analysis. Of these participants, 86 patients (14.9%) had baseline hyperphosphatemia of whom 75.6% (65 of 86) had CKD stage 4/5 and 31.1% (153 of 492) with sP≤4.5mg/dL h...
These were post hoc analyses, no placebo comparison was performed due to the design of the original studies, and the follow-up period was limited to 4 weeks....
Reductions in sP and sK...
In this case report, a novel N-acetylgalactosaminyltransferase 3 homozygous mutation (c.782 G>A; p.R261Q) associated with hyperphosphatemic familial tumoral calcinosis/hyperostosis-hyperphosphatemia s...